• Products
  • Catalogs
  • News & Trends
  • Exhibitions

Clinical chemistry reagent CPK – MB
blood samplecreatine phosphokinase

clinical chemistry reagent
clinical chemistry reagent
Add to favorites
Compare this product
 

Characteristics

Applications
for clinical chemistry, blood sample
Tested parameter
creatine phosphokinase

Description

OVERVIEW Creatine kinase (ATP: Creatine N-phosphotransferase, EC2.7.3.2) is a dimeric enzymecomposed of two types of monomer subunits, M (Muscular) and B (Brain). The subunits combine to form three distinct CK isoenzymes, CK-BB (CK-1), CK-MB (CK-2) and CK-MM (CK-3). CK-MM is the predominant form of CK in skeletal muscle. CK-BB is found in brainand smooth muscle. CK-MB is found in a high concentration in the myocardium (between 14 and 42%) and to a lesser extent skeletal muscle. In the absence of disease, most CKactivity in serum is due to the CK-MM isoform. Damage to the myocardium, as will occur in acute myocardial infarction (AMI), will result in increased circulating levels of the CK-MB isoform. Typically CK-MB levels become elevated 4 to 6 hours after the onset of chest pain, peak between 12 to 24 hours and return to a baseline within 48 hours. Determination of CK-MB usually on admission and at 6 hours, 12 hours, and 24 hours later, is recommended when AMI is suspected. Myocardial damage is very likely when the total CK activity is above 190 U/l, the CK-MB activity is above 24 U/l (+37°C) and the CK-MB activity fraction exceeds 6% of the total.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.